HCCC Healthcare Capital Corp. - Class A

This is a blank check company.

On 7/7/2021 the company announced a pending merger with Alpha Tau Medical Limited , the developer of the pioneering alpha-radiation cancer therapy Alpha DaRT.  

As of 10/27/2021     IEX book   CBOE book

Security Information
Category1:  US Equity
Category2:  Common stocks
Category3:  Micro cap
GICS sector:  Financials
Industry:  Shell Companies
Index country:  USA
Country of incorporation:  
IPO date:  02/21/2017
Outstanding shares:  27,500,000
Average volume:  156,426
Market cap:   $272,525,000
Current dividend yield:  0.00%
All SEC filings:     SEC Edgar Online
Quarterly filings:   10-Q
Annual filings:      10-K
Valuation   (See tab for details)
PE ratio:   -283.48
PB ratio:   68.48
PS ratio:   -163.39
Return on equity:   1.62%
Net income %:   0.00%

2021 © Stock Market MBA, Inc. Terms of use | Privacy policy